{"id":"W4407753578","doi":"10.1038/s41433-025-03732-2","title":"Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally","year":2025,"lang":"en","type":"article","venue":"Eye","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"ASTER","funders":"University of California, Irvine; Research to Prevent Blindness","keywords":"Biosimilar; Aflibercept; Medicine; Bevacizumab; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008206947,0.000370221,0.0004950431,0.0001906491,0.0004992057,0.00008215218,0.0009906207,0.0004311738,0.001725903],"category_scores_gemma":[0.000200635,0.0002266765,0.0003261977,0.0007315016,0.0006971853,0.00009861811,0.0003822134,0.0006782346,0.0004342686],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005934822,"about_ca_system_score_gemma":0.00009430496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004313144,"about_ca_topic_score_gemma":0.0002328011,"domain_scores_codex":[0.9976246,0.0005210161,0.0004711647,0.0005786006,0.00008729741,0.0007172713],"domain_scores_gemma":[0.9985681,0.0003519401,0.0001129087,0.0008232696,0.0001026649,0.00004115332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002407833,0.0005393485,0.0172588,0.00007172688,0.001159865,0.00002671422,0.0003297933,0.000004221824,0.2440575,0.02287001,0.6750425,0.0383988],"study_design_scores_gemma":[0.0008011343,0.0000787764,0.02413175,0.00009326484,0.0002144735,0.000008125,0.0001490788,0.0000176099,0.04868115,0.003270488,0.9222175,0.0003366862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1140082,0.04084935,0.00305405,0.3687033,0.01375294,0.002443575,0.0006273051,0.001276343,0.4552849],"genre_scores_gemma":[0.8514504,0.0006941317,0.001676516,0.04288689,0.0001845049,0.00003611204,0.00004116336,0.00004399398,0.1029863],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7374422,"threshold_uncertainty_score":0.9991866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01368515434072401,"score_gpt":0.2964538727724531,"score_spread":0.282768718431729,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}